2011. ISPOR European Congress – The Impact of Regulatory (FDA and EMA) and EUNETHTA Guidelines on Patient-Reported Outcomes and Health-Related Quality of Life on Market Authorisation and Pricing

Arnould B, Pavlovic M, Symonds T, Abetz L. Issue Panel 5: The Impact of Regulatory (FDA and EMA) and EUNETHTA Guidelines on Patient-Reported Outcomes and Health-Related Quality of Life on Market Authorisation and Pricing. Presented at: ISPOR 14th Annual European Congress; November 6, 2011; Madrid, Spain.